Clinical Trial Update: Preventive EXACYL® on Perioperative Bleeding During Orthognathism of Maxillary Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial of EXACYL for preventing perioperative bleeding during orthognathic surgery for retrognathism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retrognathism

Drugs mentioned

• EXACYL

Snippet

Sponsor: University Hospital, Lille | Conditions: Peri-operative Hemorrhage or Hematoma, Surgery | Phase 3 | Status: COMPLETED